Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors
出版年份 2023 全文链接
标题
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors
作者
关键词
-
出版物
International Journal of Clinical Oncology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-05-22
DOI
10.1007/s10147-023-02345-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- NTRK fusions and Trk proteins: what are they and how to test for them
- (2021) Lawrence M. Weiss et al. HUMAN PATHOLOGY
- Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
- (2020) David S Hong et al. LANCET ONCOLOGY
- JSCO—ESMO—ASCO—JSMO—TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions
- (2020) T. Yoshino et al. ANNALS OF ONCOLOGY
- Antitumor Activity of Larotrectinib in Esophageal Carcinoma with NTRK Gene Amplification
- (2020) Dirk Hempel et al. ONCOLOGIST
- Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST)
- (2020) Mazen A. Atiq et al. MODERN PATHOLOGY
- Spotlight on the treatment of infantile fibrosarcoma in the era of neurotrophic tropomyosin receptor kinase inhibitors: International consensus and remaining controversies
- (2020) Daniel Orbach et al. EUROPEAN JOURNAL OF CANCER
- Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study
- (2019) Kuniko Sunami et al. CANCER SCIENCE
- Testing algorithm for identification of patients with TRK fusion cancer
- (2019) Frédérique Penault-Llorca et al. JOURNAL OF CLINICAL PATHOLOGY
- Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from TRK Inhibitor Therapy
- (2019) Susan J. Hsiao et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Detection of NTRK Fusions: Merits and Limitations of Current Diagnostic Platforms
- (2019) James P. Solomon et al. CANCER RESEARCH
- NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls
- (2019) James P. Solomon et al. MODERN PATHOLOGY
- Identifying patients with NTRK fusion cancer
- (2019) J P Solomon et al. ANNALS OF ONCOLOGY
- PPM11 TUMOUR-SPECIFIC RANDOMIZED CONTROLLED TRIALS IN RARE ONCOGENE-DRIVEN CANCERS: ASKING FOR THE IMPOSSIBLE?
- (2019) G. Lozano-Ortega et al. VALUE IN HEALTH
- Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
- (2019) Ana S. Guerreiro Stucklin et al. Nature Communications
- Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
- (2019) Robert C Doebele et al. LANCET ONCOLOGY
- Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors
- (2018) Erin R. Rudzinski et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics
- (2018) Yin P Hung et al. HISTOPATHOLOGY
- Comparison of molecular testing modalities for detection of ROS1 rearrangements in a cohort of positive patient samples
- (2018) Kurtis D. Davies et al. Journal of Thoracic Oncology
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Use of Neoadjuvant Larotrectinib in the Management of Children With Locally Advanced TRK Fusion Sarcomas
- (2018) Steven G. DuBois et al. CANCER
- Molecular characterization of cancers with NTRK gene fusions
- (2018) Zoran Gatalica et al. MODERN PATHOLOGY
- Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front Mutations
- (2018) Alexander Drilon et al. Cancer Discovery
- TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening
- (2018) Catherine M. Albert et al. JOURNAL OF CLINICAL ONCOLOGY
- NTRK fusion-positive cancers and TRK inhibitor therapy
- (2018) Emiliano Cocco et al. Nature Reviews Clinical Oncology
- ETV6 -NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study
- (2017) Christian Vokuhl et al. PEDIATRIC BLOOD & CANCER
- A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion–Positive Solid Tumors
- (2017) Alexander Drilon et al. Cancer Discovery
- Detecting Gene Rearrangements in Patient Populations Through a 2-Step Diagnostic Test Comprised of Rapid IHC Enrichment Followed by Sensitive Next-Generation Sequencing
- (2017) Danielle A. Murphy et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Mammary Analogue Secretory Carcinoma of Salivary Glands
- (2016) Alena Skálová et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experience
- (2016) Daniel Orbach et al. EUROPEAN JOURNAL OF CANCER
- Transcriptome sequencing identifiesETV6-NTRK3as a gene fusion involved in GIST
- (2016) Monica Brenca et al. JOURNAL OF PATHOLOGY
- Secretory Breast Carcinoma
- (2015) Marie Del Castillo et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer
- (2015) M. Russo et al. Cancer Discovery
- The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
- (2014) Gang Wu et al. NATURE GENETICS
- TRKing Down an Old Oncogene in a New Era of Targeted Therapy
- (2014) Aria Vaishnavi et al. Cancer Discovery
- Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma
- (2013) Justin A. Bishop et al. HUMAN PATHOLOGY
- Mammary analogue secretory carcinoma: Update on a new diagnosis of salivary gland malignancy
- (2013) Roshan Sethi et al. LARYNGOSCOPE
- Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor Entity
- (2010) Alena Skálová et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started